"The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
Opioids are a class of drugs that are used to treat and manage pain. A comm"...
VIOKASE® (pancrelipase tablets, powder) should not be held in the mouth as the proteolytic action may cause irritation of the mucosa.
Avoid inhalation of the powder when administering VIOKASE® (pancrelipase tablets, powder) .
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Last reviewed on RxList: 12/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Viokase Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.